Thryve Wealth Management’s Amgen AMGN Stock Holding History

Thryve Wealth Management’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,037	Closed	-$339K	–	45
2025 Q4	$339K	Buy	+1,037	New	+$329K	0.17%	72

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Thryve Wealth Management's AMGN Position: Q1 2026 in Review

Thryve Wealth Management sold out of Amgen (AMGN) in Q1 2026, closing a stake of 1,037 shares — an estimated $339K sold.

Thryve Wealth Management first reported a position in AMGN in Q4 2025 and held it in 1 quarter. The position peaked at $339K in Q4 2025. 3,142 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Thryve Wealth Management reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
Thryve Wealth Management sold 1,037 Amgen shares in Q1 2026, an estimated $339K.
Thryve Wealth Management first reported a position in Amgen in Q4 2025 and held it in 1 quarter.
Thryve Wealth Management's Amgen position peaked at $339K in Q4 2025.
3,142 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Thryve Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.